Effect of CD44 expression on T cell acute lymphocytic leukemia

作者: Ronny R. Racine

DOI:

关键词:

摘要: CD44 is a cell surface glycoprotein that serves as multifunctional receptor aiding in trafficking and adhesion of immune cells. also recruitment platform for signaling molecules has been shown to regulate proliferation. In several types leukemia the presence or absence expression associated with different clinical outcomes, patients who have increased exhibiting stronger response conventional chemoand radiotherapy. By using Jurkat T cells, which do not express CD44, determine effects model Acute Lymphocytic Leukemia line, we outlined two major areas study. Firstly, upon cells proliferate slowly compared control This decrease proliferation coupled an arrest cycle during transition from G1 phase into S phase. The dysregulation induced by leads induction aneuploidy. expressing reduced mRNA key regulators chromosome separation mitotic spindle complex. finding, decreased EGR-1 expression, controls cyclins responsible phase, unstable phenotype proliferates accumulates extra chromosomes daughter second area study focuses on mechanism at results observed decreases proliferation, Akt activation, expression. We show four five times higher calcium influx when rest vector due activating inducible release activated channel. excess activates calcium-activated phosphatases kinases, disrupting inducing hypophosphorylation Akt. Together, these findings indicate can signal transduction pathways addition its role adhesion. Thus, our data provide further understanding how modifies leukemic are favorable therapeutic intervention. EFFECT OF EXPRESSION ON CELL ACUTE LYMPHOCYTIC LEUKEMIA

参考文章(113)
Mohammed Ibrahim Sayed Ahmed, Hoda Mohammed Abo El Fotoh Hassab, Study of soluble CD44 and its expression by mononuclear cells in children with acute lymphoblastic leukemia: its relation to prognostic factors. The Egyptian journal of immunology / Egyptian Association of Immunologists. ,vol. 15, pp. 101- 111 ,(2008)
Gerald Thiel, Sabine I. Mayer, Isabelle Müller, Luisa Stefano, Oliver G. Rössler, Egr-1—A Ca2+-regulated transcription factor Cell Calcium. ,vol. 47, pp. 397- 403 ,(2010) , 10.1016/J.CECA.2010.02.005
L.-S. Zhang, H.-W. Ma, H. J. Greyner, W. Zuo, M. E. Mummert, Inhibition of cell proliferation by CD44: Akt is inactivated and EGR-1 is down-regulated. Cell Proliferation. ,vol. 43, pp. 385- 395 ,(2010) , 10.1111/J.1365-2184.2010.00689.X
Michael F Ritchie, Yandong Zhou, Jonathan Soboloff, WT1/EGR1-mediated control of STIM1 expression and function in cancer cells. Frontiers in Bioscience. ,vol. 16, pp. 2402- 2415 ,(2011) , 10.2741/3862
Hongchun Wu, Jieqiong Deng, Jian Zheng, Yonghe You, Na Li, Wei Li, Depei Wu, Yifeng Zhou, Functional polymorphisms in the CD44 gene and acute myeloid leukemia cancer risk in a Chinese population. Molecular Carcinogenesis. ,vol. 54, pp. 102- 110 ,(2015) , 10.1002/MC.22078
Naveed I. Khan, Adam Cisterne, Meenakshi Devidas, Jonathan Shuster, Stephen P. Hunger, Peter J. Shaw, Kenneth F. Bradstock, Linda J. Bendall, Expression of CD44, but not CD44v6, predicts relapse in children with B cell progenitor acute lymphoblastic leukemia lacking adverse or favorable genetics. Leukemia & Lymphoma. ,vol. 49, pp. 710- 718 ,(2008) , 10.1080/10428190701861660
Vishva Mitra Sharma, Kyle M. Draheim, Michelle A. Kelliher, The Notch1/c-Myc pathway in T cell leukemia. Cell Cycle. ,vol. 6, pp. 927- 930 ,(2007) , 10.4161/CC.6.8.4134
Natalie O. Karpinich, Marco Tafani, Timothy Schneider, Matteo A. Russo, John L. Farber, The course of etoposide‐induced apoptosis in Jurkat cells lacking p53 and Bax Journal of Cellular Physiology. ,vol. 208, pp. 55- 63 ,(2006) , 10.1002/JCP.20638
Yasushi Fujio, Kenneth Walsh, Akt Mediates Cytoprotection of Endothelial Cells by Vascular Endothelial Growth Factor in an Anchorage-dependent Manner Journal of Biological Chemistry. ,vol. 274, pp. 16349- 16354 ,(1999) , 10.1074/JBC.274.23.16349